The global eyelid surgery market size was valued at USD 3.3 billion in 2018 and is expected to expand at a CAGR of 5.8% by 2026. As the skin ages, it gradually loses its elasticity, thereby causing wrinkles and bulges around the eyelid. Thus, rising geriatric population and growing demand for non-invasive surgical procedures are some of the major factors driving the market.
Eyelid surgery or blepharoplasty treatment is mainly performed to enhance the aesthetic appeal of eyes by correcting baggy eyelids, droopy eyelids, and other eyelid defects & disfigurations. Through blepharoplasty, excess fatty deposits can be altered, which reduces the puffiness of the eyes. Thus, increasing the incidence of such conditions is propelling demand for eyelid surgery, thereby driving growth.
Moreover, surgeons are increasingly using non-surgical technologies for eyelid surgery owing to its various advantages over traditional surgical techniques. As compared to conventional surgeries, which consist of surgical procedures, anesthetization, and long recovery time, modern technological procedures overcome these drawbacks. For instance, modern technologies using plasma exeresis methods are cost-effective & non-invasive and have immediate effect. Such technological advancements are expected to drive the market over the forecast period.
The growing prevalence of eye-associated problems, especially in the geriatric population, is expected to aid growth. Eye conditions such as droopy eyes, blurry vision, & wrinkles near the eyes are increasing globally, thereby stimulating the need for the targeted surgeries. This will ultimately boost demand in the forecast period. Besides, the demand for better appearance is also fueling the market growth.
Eyelid problems are highly prevalent in the Asia Pacific, especially China. Annually, millions of young people in China undergo eyelid surgery due to rising disposable income, the desire to look younger, or professional reasons. According to a report by the International Society of Aesthetic Plastic Surgery, approximately 1.3 million individuals globally underwent eyelid surgery in 2017, exhibiting the high demand for the procedure across the globe.
By procedure type, the global eyelid surgery market is divided into the upper eyelid and lower eyelid surgeries. The upper eyelid surgery segment held the largest share in 2018 and is expected to be the fastest-growing segment in the forecast period owing to its high popularity compared to lower eyelid surgery.
Upper eyelid surgery removes excess skin along the upper eyelids & tightens drooping skin for better vision, which was earlier obstructed. Smoother forehead and more youthful appearance are few benefits that this surgery offers. These benefits attract consumers, which ultimately increases the demand for eyelid surgeries.
The lower eyelid surgery segment is also expected to grow significantly in the forecast period owing to its benefits. Lower eyelid surgery removes fats, loose skin, & excessive skin in the lower lids, improves under bags, reduces circles, and smoothens eyelid lines & wrinkles. Awareness of these benefits among the large population is propelling the market.
By end-use, the market is categorized into hospitals and clinics & surgery centers. Clinics & surgery centers segment held the maximum share in 2018 and is anticipated to dominate the market in the forecast period owing to an increasing number of clinics and skilled cosmetic & plastic surgeons and rising preference for blepharoplasty. Moreover, increasing the use of Botox or Dysport by clinic surgeons is propelling the market growth. These injections effectively help raise eyebrows, thereby attracting customers for cosmetic surgeries.
The hospital segment is also expected to grow significantly in the forecast period owing to factors such as improving the infrastructure of hospitals, especially in the developing economies. Also, the availability of a high number of surgeons and advanced medical instruments is propelling the growth of the hospital segment.
Geographically, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated in 2018 due to the availability of improved facilities and the growing demand for cosmetic surgery from the large millennial and geriatric population. Moreover, the quick adoption of innovative techniques and devices by the region is fueling the market.
The Asia Pacific is expected to witness rapid growth over the forecast period. This can be attributed to the increasing aging population, rising demand for cosmetic surgery, and gaining popularity of blepharoplasty as a medical treatment. Besides, a growing number of patients undergoing eyelid surgery in economies such as South Korea & Japan and expanding the cosmetic industry in India & China is expected to fuel growth in the forecast period. The rising number of eyelid surgeries in China is majorly due to increasing disposable income, growing acceptance of various cosmetic surgeries, and willingness to spend on improving appearance.
Latin America is also expected to grow considerably in the forecast period owing to a rise in the number of cosmetic surgeries. For instance, in 2015, Brazil recorded a total of 2,324,245 cosmetic procedures, just behind the U.S. Latin America offers medical surgeries at a relatively lower cost compared to the U.S., thereby increasing medical tourism in this region.
Some of the key players are Stanford Health Care, USA Plastic Surgery, London Bridge Plastic Surgery, Montenegro Clinic of Plastic Surgery, and Shoyukai. The abovementioned players are focusing on increasing their credibility to provide enhanced services to blepharoplasty patients. The board-certified surgeons at these clinics & hospitals are specifically trained and have extensive experience in cosmetic procedures. Hence, all the surgeries are performed in an accredited surgical facility. The team of surgeons and medical experts at The University of Michigan guide their patients through every step of the procedure for the best results. They also provide personalized care by conducting pre-operative and post-operative visits at Domino’s Farms.
Report Attribute |
Details |
The market size value in 2020 |
USD 3.71 billion |
The revenue forecast in 2026 |
USD 5.2 billion |
Growth Rate |
CAGR of 5.8% from 2019 to 2026 |
The base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Procedure type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Thailand; South Korea; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Stanford Health Care; USA Plastic Surgery; London Bridge Plastic Surgery; Montenegro Clinic of Plastic Surgery; Shoyukai |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For this report, Grand View Research has segmented the global eyelid surgery market report based on procedure type, end-use, and region:
Procedure Type Outlook (Revenue, USD Million, 2015 - 2026)
Upper Eyelid Surgery
Lower Eyelid Surgery
End-use Outlook (Revenue, USD Million, 2015 - 2026)
Hospitals
Clinics & Surgery Centers
Regional Outlook (Revenue, USD Million, 2015 - 2026)
North America
The U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Columbia
MEA
South Africa
Saudi Arabia
UAE
b. The global eyelid surgery market size was estimated at USD 3.52 billion in 2019 and is expected to reach USD 3.71 billion in 2020.
b. The global eyelid surgery market is expected to grow at a compound annual growth rate of 5.8% from 2019 to 2026 to reach USD 5.22 billion by 2026.
b. North America dominated the eyelid surgery market with a share of 43.6% in 2019. This is attributable to availability of improved facilities and growing demand for cosmetic surgery from the millennials as well as geriatric population.
b. Some key players operating in the eyelid surgery market include Stanford Health Care, USA Plastic Surgery, London Bridge Plastic Surgery, Montenegro Clinic of Plastic Surgery, and Shoyukai.
b. Key factors that are driving the market growth include rising geriatric population and growing demand for non-invasive surgical procedures.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."